Toll-like receptor signaling: a perspective to develop vaccine against leishmaniasis

Microbiol Res. 2012 Sep 6;167(8):445-51. doi: 10.1016/j.micres.2012.01.002. Epub 2012 Feb 10.

Abstract

The toll-like receptors (TLRs) are the sentinel factor of the innate immunity, which are essential for host defense. These receptors detect the presence of conserved molecular patterns of potentially pathogenic microorganisms and contribute in both, cellular as well as humoral immune responses. Leishmania is an intracellular pathogen that silently invades host immune system. After phagocytosis, it divides and proliferates in the harmful environment of host macrophages by down-regulating its vital effector functions. In leishmaniasis, the outcome of the infection basically relies on the skewed balance between Th1/Th2 immune responses. Lots of work have been done and on progress but still characterization of either preventive or prophylactic candidate antigen/s is far from satisfactory. How does Leishmania regulate host innate immune system? Still it is unanswered. TLRs play very important role during inflammatory process of various diseases such as cancer, bacterial and viral infections but TLR signaling is comparatively less explained in leishmanial infection. In the context to Th1/Th2 dichotomy, identification of leishmanial antigens that modulate toll-like receptor signaling will certainly help in the development of future vaccine. This review will initially describe global properties of TLRs, and later will discuss their role in the pathogenesis of leishmaniasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Leishmania / immunology*
  • Leishmania / pathogenicity*
  • Leishmaniasis / immunology
  • Leishmaniasis / prevention & control*
  • Leishmaniasis Vaccines / immunology*
  • Signal Transduction*
  • Toll-Like Receptors / immunology*

Substances

  • Leishmaniasis Vaccines
  • Toll-Like Receptors